213 related articles for article (PubMed ID: 12075261)
1. Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction.
Jeremias A; Albirini A; Ziada KM; Chew DP; Brener SJ; Topol EJ; Ellis SG
Am Heart J; 2002 Jun; 143(6):1040-5. PubMed ID: 12075261
[TBL] [Abstract][Full Text] [Related]
2. Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure.
Gruberg L; Mehran R; Waksman R; Dangas G; Fuchs S; Wu H; Kent KM; Pichard AD; Satler LF; Stone GW; Leon MB
Am J Cardiol; 2001 Jun; 87(12):1356-60. PubMed ID: 11397353
[TBL] [Abstract][Full Text] [Related]
3. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality.
Brener SJ; Lytle BW; Schneider JP; Ellis SG; Topol EJ
J Am Coll Cardiol; 2002 Dec; 40(11):1961-7. PubMed ID: 12475456
[TBL] [Abstract][Full Text] [Related]
4. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality.
Kini AS; Lee P; Marmur JD; Agarwal A; Duffy ME; Kim MC; Sharma SK
Am J Cardiol; 2004 Jan; 93(1):18-23. PubMed ID: 14697460
[TBL] [Abstract][Full Text] [Related]
5. Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting.
Saucedo JF; Mehran R; Dangas G; Hong MK; Lansky A; Kent KM; Satler LF; Pichard AD; Stone GW; Leon MB
J Am Coll Cardiol; 2000 Apr; 35(5):1134-41. PubMed ID: 10758952
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II.
Tardiff BE; Califf RM; Tcheng JE; Lincoff AM; Sigmon KN; Harrington RA; Mahaffey KW; Ohman EM; Teirstein PS; Blankenship JC; Kitt MM; Topol EJ
J Am Coll Cardiol; 1999 Jan; 33(1):88-96. PubMed ID: 9935014
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of cardiac troponin I elevation after percutaneous coronary intervention in patients with chronic renal insufficiency: a 12-month outcome analysis.
Gruberg L; Fuchs S; Waksman R; Pichard AD; Kent KM; Laird JR; Wu H; Elsayyad S; Allen CM; Satler LF
Catheter Cardiovasc Interv; 2002 Feb; 55(2):174-9. PubMed ID: 11835642
[TBL] [Abstract][Full Text] [Related]
8. Does creatine kinase-MB (CK-MB) isoenzyme elevation following percutaneous coronary intervention with drug-eluting stents impact late clinical outcome?
Javaid A; Buch AN; Steinberg DH; Pinto Slottow T; Roy P; Pichard AD; Satler LF; Kent KM; Gevorkian N; Xue Z; Suddath WO; Waksman R
Catheter Cardiovasc Interv; 2007 Nov; 70(6):826-31. PubMed ID: 17621656
[TBL] [Abstract][Full Text] [Related]
9. Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: an ESPRIT substudy.
Gibson CM; Murphy SA; Marble SJ; Cohen DJ; Cohen EA; Lui HK; Young J; Kitt MM; Lorenz TJ; Tcheng JE
Am Heart J; 2002 Jan; 143(1):106-10. PubMed ID: 11773919
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of recurrent episodes of creatine kinase-MB elevation following repeated catheter-based coronary interventions.
Kornowski R; Fuchs S; Hong MK; Mehran R; Satler LF; Pichard AD; Kent KM; Stone GW; Leon MB
Catheter Cardiovasc Interv; 2000 Oct; 51(2):131-7. PubMed ID: 11025563
[TBL] [Abstract][Full Text] [Related]
11. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?
Akkerhuis KM; Alexander JH; Tardiff BE; Boersma E; Harrington RA; Lincoff AM; Simoons ML
Circulation; 2002 Feb; 105(5):554-6. PubMed ID: 11827918
[TBL] [Abstract][Full Text] [Related]
12. Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention.
Andron M; Stables RH; Egred M; Alahmar AE; Shaw MA; Roberts E; Albouaini K; Grayson AD; Perry RA; Palmer ND
J Invasive Cardiol; 2008 Mar; 20(3):108-12. PubMed ID: 18316825
[TBL] [Abstract][Full Text] [Related]
13. Treatment modalities of non-ST-elevation acute coronary syndromes in the real world. Results of the prospective R.OS.A.I.-2 registry.
Registro Osservazionale Angina Instabile Investigators
Ital Heart J; 2003 Nov; 4(11):782-90. PubMed ID: 14699708
[TBL] [Abstract][Full Text] [Related]
14. Troponin I elevation and cardiac events after percutaneous coronary intervention.
Ricciardi MJ; Davidson CJ; Gubernikoff G; Beohar N; Eckman LJ; Parker MA; Bonow RO
Am Heart J; 2003 Mar; 145(3):522-8. PubMed ID: 12660677
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
[TBL] [Abstract][Full Text] [Related]
16. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention.
Kini A; Marmur JD; Kini S; Dangas G; Cocke TP; Wallenstein S; Brown E; Ambrose JA; Sharma SK
J Am Coll Cardiol; 1999 Sep; 34(3):663-71. PubMed ID: 10483945
[TBL] [Abstract][Full Text] [Related]
17. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.
Roe MT; Mahaffey KW; Kilaru R; Alexander JH; Akkerhuis KM; Simoons ML; Harrington RA; Tardiff BE; Granger CB; Ohman EM; Moliterno DJ; Lincoff AM; Armstrong PW; Van de Werf F; Califf RM; Topol EJ
Eur Heart J; 2004 Feb; 25(4):313-21. PubMed ID: 14984920
[TBL] [Abstract][Full Text] [Related]
18. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention.
Ioannidis JP; Karvouni E; Katritsis DG
J Am Coll Cardiol; 2003 Oct; 42(8):1406-11. PubMed ID: 14563583
[TBL] [Abstract][Full Text] [Related]
19. Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions.
Abdelmeguid AE; Ellis SG; Sapp SK; Whitlow PL; Topol EJ
Am Heart J; 1996 Jun; 131(6):1097-105. PubMed ID: 8644587
[TBL] [Abstract][Full Text] [Related]
20. Causes of acute renal dysfunction after percutaneous coronary intervention and comparison of late mortality rates with postprocedure rise of creatine kinase-MB versus rise of serum creatinine.
Lindsay J; Canos DA; Apple S; Pinnow E; Aggrey GK; Pichard AD
Am J Cardiol; 2004 Sep; 94(6):786-9. PubMed ID: 15374790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
